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Extracellular neutrophil traps (NETs) have
gathered lots of attention in recent years
with regard to pathogenesis of diverse
inflammatory and autoimmune diseases
[gout, systemic lupus erythematosus
(SLE), and vasculitis] (Kessenbrock et al.,
2009; Bosch, 2011; Mitroulis et al., 2011).
It seems that neutrophils are not only basic
players and mediators of innate immunity,
but are also involved in activation, regu-
lation, and effector functions of adaptive
immune cells (Mantovani et al., 2011).
Neutrophils are considered as the
mainstay of cellular innate immune
responses. During the infection, numer-
ous neutrophils infiltrate the affected
tissue, trying to eradicate the bacteria
by phagocytosis (Nathan, 2006), and
generate chemotactic signals that attract
monocytes and dendritic cells (Bennouna
et al., 2003). However, occasionally, the
above mechanism seems to be ineffec-
tive in vivo due to the flow dynamics
of circulation (Phillipson and Kubes,
2011). Thus, neutrophils have adopted
other more effective defense mecha-
nisms. They can release their DNA in
the presence of bacteria-creating traps
called NETs—a weave of DNA fibers
consisting of histones and antimicrobial
proteins [myeloperoxidase (MPO), elas-
tase, proteinase 3 (PR3)]—with a strong
antibacterial effect (Brinkmann et al.,
2004). Nevertheless, besides the beneficial
role during infections, NETs can injure the
endothelium leading to irreversible dam-
age (Xu et al., 2009). In addition, NETs
can serve as autoantigens that activate the
plasmacytoid dendritic cells (pDCs) that
in turn trigger B cells’ activation, enhanc-
ing by this way autoantibody production
(Lande et al., 2011).
In the present case study (Nakazawa
et al., 2012b), the abundant existence of
NETs in a thrombus of a patient who
died from a fulminant multi-organ micro-
scopic polyangiitis (MPA) is described
for the first time. In addition, the study
confirms previous reports showing pres-
ence of NETs in the glomeruli in kid-
neys affected by MPA (Kessenbrock et al.,
2009). It appears that the presence of
thrombocytes is essential for the forma-
tion of NETs. Thrombocytes can bind to
different types of leucocytes enhancing the
production of numerous inflammatory
molecules (Semple et al., 2011). Activated
neutrophils alone do not appear to dam-
age the endothelium, however, the binding
of stimulated thrombocytes to neutrophils
induces endothelial cell-death through the
development of NETs (Clark et al., 2007).
In turn, NETs provide a framework for
thrombocytes’ adhesion, leading to firm
thrombus formation (Fuchs et al., 2010;
Nakazawa et al., 2012b).
In the renal tissue of patients suffer-
ing from systemic small-vessel vasculitis,
NETs have been shown to be directly
involved in the endothelial damage caused
by anti-neutrophil cytoplasmic antibod-
ies (ANCA) (Kessenbrock et al., 2009).
NETs seem to substantially enhance the
uptake of PR3 and MPO molecules by
myeloid dendritic cells (mDCs), lead-
ing to a significant induction of ANCA
production and subsequent endothelial
damage in renal and pulmonary tissue in
mice (Sangaletti et al., 2012). In another
study by Nakazawa et al. the use of
propylthiouracil in rat neutrophils caused
induction of abnormalNETs and led to the
further development of MPO-ANCA and
pulmonary capillaritis (Nakazawa et al.,
2012a). Sangaletti et al. showed that inhi-
bition of the NETs’ production with
deoxyribonuclease (DNAse), which selec-
tively digests NETs DNA, prevented load-
ing of PR3 and MPO by mDCs and led to
inhibition of vasculitis.
The existence of NETs in the differ-
ent organs affected by vasculitis raises an
interesting question of whether or not
the neutrophils undergoing cell-death by
NETs could be a worthwhile therapeu-
tic target. Taking into account all of the
above, it seems that in pathological neu-
trophil activation, targeting the extracellu-
lar DNA and histones in NETs by DNAse
may be beneficial by preventing throm-
bosis and irreversible end-organ dam-
age induced by vasculitis. In addition,
inhibition of peptidelargine deaminase
4 (PAD4), which citrullinates histones, and
nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase-which generates
reactive oxygen species—both essential for
NETs formation, could be an interest-
ing therapeutic target (Nakazawa et al.,
2012b).
The study of Nakazawa et al. is also
important for another reason. It reminds
us of how difficult can be the diag-
nosis of the ANCA-associated vasculitis
presenting with dramatic manifestations
of multi-organ failure. In these patients,
immediate initiation of treatment is cru-
cial in order to diminish the end-organ
www.frontiersin.org February 2013 | Volume 4 | Article 24 | 1
Diamantopoulos NETs in ANCA-associated vasculitis
damage and protect the vital functions
of the affected individual. However, the
meticulous clinician should always keep
in mind that intense signs of inflam-
mation and multi-organ failure can also
be seen in other conditions, such as
infections.
In conclusion, further studies are
needed to explore the therapeutic
implication of targeting NETs in the
ANCA-associated vasculitis. Prompt initi-
ation of treatment in patients suffering
from ANCA-associated vasculitis can
secure the best outcomes.
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